(0.27%) 5 120.50 points
(0.05%) 38 744 points
(0.70%) 17 730 points
(0.17%) $83.50
(-0.22%) $1.808
(-0.21%) $2 337.20
(-0.04%) $27.35
(-0.22%) $920.80
(0.13%) $0.935
(0.13%) $10.92
(0.14%) $0.804
(-0.49%) $92.73
Live Chart Being Loaded With Signals
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions...
Stats | |
---|---|
Today's Volume | 631.00 |
Average Volume | 2 562.00 |
Market Cap | 46.40M |
EPS | $0 ( 2024-03-13 ) |
Last Dividend | $0.0300 ( 2018-01-05 ) |
Next Dividend | $0 ( N/A ) |
P/E | 70.00 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-27 | Michel Robert J | Buy | 750 | Daxor Common Stock |
2024-03-04 | Feuer Edward | Buy | 1 000 | Daxor Common Stock |
2023-12-06 | Michel Robert J | Buy | 120 | Daxor Common Stock |
2023-12-01 | Michel Robert J | Buy | 180 | Daxor Common Stock |
2023-12-01 | Feldschuh Michael Richard | Buy | 800 | Daxor Common Stock |
INSIDER POWER |
---|
56.91 |
Last 97 transactions |
Buy: 668 992 | Sell: 434 444 |
Daxor Corp Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Daxor Corp Financials
Annual | 2023 |
Revenue: | $34.59M |
Gross Profit: | $34.41M (99.49 %) |
EPS: | $0.0606 |
Q4 | 2023 |
Revenue: | $36.35M |
Gross Profit: | $36.36M (100.01 %) |
EPS: | $0.690 |
Q2 | 2023 |
Revenue: | $-1.76M |
Gross Profit: | $-2.20M (124.95 %) |
EPS: | $-0.680 |
Q1 | 2023 |
Revenue: | $40 487.00 |
Gross Profit: | $40 487.00 (100.00 %) |
EPS: | $-0.320 |
Financial Reports:
No articles found.
Daxor Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.500 | 1997-04-28 |
Last Dividend | $0.0300 | 2018-01-05 |
Next Dividend | $0 | N/A |
Payout Date | 2018-01-12 | |
Next Payout Date | N/A | |
# dividends | 20 | -- |
Total Paid Out | $5.11 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.55 | -- |
Div. Sustainability Score | 5.50 | |
Div.Growth Potential Score | 0.167 | |
Div. Directional Score | 2.83 | -- |
Year | Amount | Yield |
---|
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
JZRO | Ex Dividend Junior | 2023-06-30 | Quarterly | 0 | 0.00% | |
RIET | Ex Dividend Junior | 2023-09-12 | Monthly | 0 | 0.00% | |
AIVI | Ex Dividend Junior | 2023-06-26 | Quarterly | 0 | 0.00% | |
EIM | Ex Dividend King | 2023-09-21 | Monthly | 0 | 0.00% | |
IAF | Ex Dividend Junior | 2023-08-23 | Quarterly | 0 | 0.00% | |
PFRL | Ex Dividend Junior | 2023-08-01 | Monthly | 0 | 0.00% | |
DFAT | Ex Dividend Junior | 2023-09-19 | Quarterly | 0 | 0.00% | |
GLQ | Ex Dividend Knight | 2023-09-21 | Monthly | 0 | 0.00% | |
NOG | Ex Dividend Knight | 2023-09-27 | Quarterly | 0 | 0.00% | |
COHN | Ex Dividend Junior | 2023-08-17 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.168 | 1.500 | 6.65 | 9.97 | [0 - 0.5] |
returnOnAssetsTTM | 0.165 | 1.200 | 4.50 | 5.40 | [0 - 0.3] |
returnOnEquityTTM | 0.186 | 1.500 | 9.04 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0.0217 | -1.500 | 9.64 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 73.38 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | -2.02 | 2.00 | -0.672 | -1.344 | [0 - 30] |
freeCashFlowPerShareTTM | -2.02 | 2.00 | -1.008 | -2.02 | [0 - 20] |
debtEquityRatioTTM | 0.0222 | -1.500 | 9.91 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.966 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.202 | 1.000 | 7.96 | 7.96 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -12.82 | 1.000 | -10.00 | -10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.984 | 0.800 | 6.77 | 5.42 | [0.5 - 2] |
Total Score | 5.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 7.85 | 1.000 | 9.31 | 0 | [1 - 100] |
returnOnEquityTTM | 0.186 | 2.50 | 9.39 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -2.02 | 2.00 | -0.672 | -2.02 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -2.02 | 2.00 | -0.672 | -1.344 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.0392 | 1.500 | -3.59 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.282 | 1.000 | -9.56 | 0 | [0.1 - 0.5] |
Total Score | 0.167 |
Daxor Corp
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators